title: Telltale signs of progress in the management of thrombotic thrombocytopenic purpura.
authors.forename: Joseph E
authors.initials: JE
authors.lastname: Kiss
authors.forename: Lynne
authors.initials: L
authors.lastname: Uhl
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000401:mortality* / Q000628:therapy*; D006801:Humans; D008297:Male; D010951:Plasma Exchange / Q000009:adverse effects* / Q000401:mortality*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000188:drug therapy* / Q000401:mortality* / Q000628:therapy*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab